Healthcare Fund - Invest in DSP Healthcare Fund Direct IDCW Online

arrow_back

DSP Healthcare Fund

Benchmark: BSE HEALTHCARE (TRI)

1.61 lakh people have invested in this fund

LumpsumMonthly SIPView performance details

Return:

Annualized

Absolute

This fund

18.00%

BSE HEALTHCARE (TRI)

14.30%

NIFTY 50 TRI

14.15%

team 1.61 lakh people have invested in this fund as of

This is an Equity Sectoral/Thematic, Pharma fund with BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk.

Total AUM

₹2,934.17 crores as of Aug 31, 2024

Age of Fund

5 years 9 months since Nov 30, 2018

Expense Ratio

0.56% as of Sep 09, 2024

Exit Load

0.5% If redeemed between 0 - 1 Months

Ideal holding period

10 Years+

Holdings

as of Aug 31, 2024

Sun Pharmaceutical Industries Limited

11.64%

Suven Pharmaceuticals Limited

10.08%

Lupin Limited

8.34%

Cipla Limited

7.82%

IPCA Laboratories Limited

7.57%

Alembic Pharmaceuticals Limited

5.14%

Globus Medical Inc

5.09%

See all 29 holdings

Rolling Returns

Bars show distribution of returns in given range for selected time period.

View performance details

Things to know before you invest

What is in DSP Healthcare Fund?

This thematic fund invests in established & upcoming companies in the pharmaceutical & healthcare space in India and internationally (primarily, the United States).
It can have up to 25% allocation to global stocks to provide access to sectors less developed or available in India.
It considers companies who 'help people get well soon' across the healthcare spectrum- including pharmaceuticals, hospitals, diagnostics etc.

Why should one invest in DSP Healthcare Fund?

Offers the potential to grow your wealth & 'earn big' returns if this theme does well (a high-risk, high-return strategy).
Favourable sector dynamics- Rising income levels, increasing health-consciousness, government policies means an increase in healthcare spending, so companies in this space could do well.
The up to 25% international exposure with low correlation to Indian healthcare companies means healthy diversification.
Can help you beat the impact of rising prices over the long-term.
Can be a suitable choice for tactical allocation.

Who should invest in DSP Healthcare Fund?

Consider this fund if you
- Are an experienced investor with a well-set core portfolio & know what you're doing.
- Are looking to tactically allocate 10-15% of your overall portfolio to very high-risk opportunities.
- Understand that there is very high risk involved in this category of funds in the quest for high returns.
- Have the patience and sectoral understanding to 'extract value' from changing sector cycles.

Rethink before you invest

This is a sectoral/ thematic fund, therefore its NAV is likely to fluctuate a lot more than diversified equity funds.
Please do not use recent or past returns as the only criteria to evaluate this fund.
Healthcare fund carries Very High Risk.

Fund managers:

Chirag Dagli

Total work experience of 23 years. Managing this fund since December 2020

See funds managed by him

See his investing philosophy

Total work experience of 23 years. Managing this fund since December 2020

See funds managed by him

See his investing philosophy

Chirag has a total work experience of Over 20 years. He joined DSP Mutual Fund in November 2020 as Vice President in Equity Team.
Chirag has also worked with HDFC AMC Limited, Aviva life Insurance, ICICI Securities, Infinity.com Financial Services Limited, Global Markets - Deutsche Equities India Private Limited, Citigroup Global Markets India Private Limited and ICICI Securities. He is a Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree.

Sr. No.	Scheme Name	Managing since	Period
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Sr. No.

Scheme Name

Managing since

Period

1 Years

3 Years

5 Years

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Portfolio

Prescribed asset allocation: 80% - 100% Equity and equity related securities of pharmaceutical and healthcare companies , 0% - 20% Equity and Equity related securities of other Companies , 0% - 20% Debt, securitized debt and Money Market Securities , 0% - 10% Units of REITs & InvITs

Current Allocation

as of Aug 31, 2024

Equity 94.37%
Debt / cash 2.14%

Equity
Debt / Cash

Top holdings

Sun Pharmaceutical Industries Limited

11.64%

Suven Pharmaceuticals Limited

10.08%

Lupin Limited

8.34%

Cipla Limited

7.82%

IPCA Laboratories Limited

7.57%

Allocation by Market Cap

Small Cap

41.90%

Large Cap

25.30%

Mid Cap

20.20%

Uncategorized

12.70%

Top Sectors

Pharmaceuticals & Biotechnology

68.77%

Healthcare Services

14.87%

Healthcare Equipment & Supplies

7.73%

Insurance

1.76%

Mutual-funds

0.80%

See all 29 holdings

Top holdings

No Data to display

Top holdings

TREPS / Reverse Repo Investments

2.14%

Cash & cash equivalents

3.49%

Credit rating profile

Cash & Equivalent

98.10%

Instrument break-up

TREPS

100.00%

See 1 holding

Indicators

Portfolio turnover ratio

0.14 last 12 months

Compare Performance

Performance highlights over last

for

investment

Cumulative returns on

Annual returns

Current value

Min CAGR:

MedianCAGR:

Max CAGR:

Good Returns

Negative Returns

vs Category

vs Benchmark

Historical Returnsas of with investment of₹10,000
As per SEBI format
As per IDCW history

	This fund		BSE HEALTHCARE (TRI) ^{^}		NIFTY 50 TRI ^#
	CAGR	Current Value	CAGR	Current Value	CAGR	Current Value

Income distribution Cum Capital Withdrawal (IDCW) Distributed

Record Date	IDCW per unit	NAV Before	NAV After

Chart type

Graph viewTable view

Invested as

Invested Amount

₹

Invested since

This fund

BSE HEALTHCARE (TRI)

NIFTY 50 TRI

Gold

PPF

	Funds	Annual returns	Current Value	Absolute Growth	IDCW paid

Chart type:

Returns RangesStatistics

Invested Amount

₹

Invested period

Funds	Minimum	Median	Maximum	% times -ve returns	% times returns > 7%

Date of allotment: Nov 30, 2018.

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of Direct Plan.

Since inception returns have been calculated from the date of allotment till June 30, 2021

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Rolling returns have been calculated based on returns from regular plan growth option.

^ Fund Benchmark # Additional Benchmark

Scheme disclaimers

Fund Details

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
There is no assurance that the investment objective of the Scheme will be realized

Fund Type

Equity – Sectoral/Thematic

Pharma

An open ended equity scheme investing in healthcare and pharmaceutical sector

Riskometer

Level of Risk in the fund

View details

Minimum Investment

Rs. 100 Lumpsum
Rs. 100 SIP– 12 instalments
Rs. 100 Minimum Additional Purchase

Fund Documents

Fund presentation

KIM and Applications

1.61 lakh peoplehave invested in this fund as of

68.77%

Name	% of Net Assets
Sun Pharmaceutical Industries Limited	11.64%
Suven Pharmaceuticals Limited	10.08%
Lupin Limited	8.34%
Cipla Limited	7.82%
IPCA Laboratories Limited	7.57%
Alembic Pharmaceuticals Limited	5.14%
Concord Biotech Limited	3.55%
Pfizer Limited	2.93%
Procter & Gamble Health Limited	2.82%
Indoco Remedies Limited	2.75%
Aarti Drugs Limited	1.47%
Unichem Laboratories Limited	1.45%
Abbott Laboratories	1.02%
Alkem Laboratories Limited	0.79%
Emcure Pharmaceuticals Limited	0.78%
Gland Pharma Limited	0.62%

14.87%

Name	% of Net Assets
Apollo Hospitals Enterprise Limited	4.40%
Vijaya Diagnostic Centre Limited	3.17%
Kovai Medical Center and Hospital Limited	3.04%
Illumina Inc	2.42%
Narayana Hrudayalaya Ltd.	1.29%
Jupiter Life Line Hospitals Limited	0.44%
Thyrocare Technologies Limited	0.07%
Grail Inc	0.04%

7.73%

Name	% of Net Assets
Globus Medical Inc	5.09%
Intuitive Surgical Inc	2.64%

1.76%

Name	% of Net Assets
ICICI Lombard General Insurance Company Limited	1.76%

0.80%

Name	% of Net Assets
Global X Funds - Global X Genomics & Biotechnology ETF	0.80%

0.44%

Name	% of Net Assets
Medplus Health Services Limited	0.44%

2.14%

Name	% of Net Assets
TREPS / Reverse Repo Investments	2.14%

100% of Debt instruments

For lumpsum investments, if the investment period is less than 1 year then same return values are displayed for absolute & XIRR. For periods above 1 year, they are annualized. 1 Year is assumed as 365 days.
Returns for investments in income distribution cum capital withdrawal (IDCW) plans of schemes are calculated after assuming that the net income distribution cum capital withdrawal (IDCW) payouts post statutory taxes & levies, are re-invested back in the scheme.
Income distribution cum capital withdrawals (IDCW) declared from benchmark's constituents isn't taken into account when comparing with investment in fund's income distribution cum capital withdrawal (IDCW) plans.
Performance is always compared against the latest benchmark of the fund irrespective of the date of change of fund's benchmark, if any.
Except when SIP tenure is since inception, for all tenures, the start day for SIP investments is considered as 1st of every month. There is no end date to SIPs for the purpose of graphs.
For the purpose of NAV date applicability, if the investment date happens to be a non-business day, next business day's NAV is applied. Investment on inception date can happen on a non-business day.
Gold prices are available post 29 JAN, 2005 & are based on daily closing values on MCX.
Investment in gold has a strong global market demand and gold is highly liquid asset.
PPF interest rate is assumed at 8.7% p.a. & interest received is compounded daily for the returns illustration in the charts.
The comparison with PPF (and other traditional saving instruments/assets) has been given for the purpose of the general information only. Investments in mutual funds should not be construed as a promise, guarantee on or a forecast of any minimum returns. Unlike traditional saving instruments there is no capital protection guarantee or assurance of any return in mutual fund investment. Traditional savings instruments are comparatively low risk products and are generally backed by the Government. Investment in mutual funds carries high risk as compared to the traditional saving instruments and any investment decision needs to be taken only after consulting the Tax Consultant or Mutual Fund Distributor.
Past performance may or may not sustain in future and should not be used as a basis for comparison with other investments. There is no assurance of any returns/capital protection/capital guarantee to the investors in any scheme of DSP Mutual Fund.
The sector(s)/stock(s)/issuer(s) mentioned in this document do not constitute any recommendation of the same and the Fund may or may not have any future position in these sector(s)/stock(s)/issuer(s).
The investment approach / framework/ strategy / portfolio / other data mentioned herein are dated and currently followed by the scheme and the same may change in future depending on market conditions and other factors.
The SIP returns are calculated by XIRR approach assuming investment of Rs. 10,000/- on the 1st working day of every month. XIRR helps in calculating return on investments given an initial and ?nal value and a series of cash in?ows and out?ows with the correct allowance for the time impact of the transactions. Load is not taken into consideration for computation of performance.

Verify your contact details

Step 2 of 3

Contact Details As Per Your KYC Records

Email ID
Mobile no.

Not able to access even the above email or mobile?
Click here to know the process of updating your contact details in KYC records.

Verify your contact details

Step 2 of 3

Thanks for your interest in investing with DSP Mutual Fund. To proceed further, we need to verify atleast 1 of your below mentioned contact details.

Contact Details As Per Your KYC Records

Email ID	ABH************[email protected]
Mobile no.	******6665

Not able to access even the above email or mobile?

Click here to know the process of updating your contact details in KYC records.

Not able to access even the above email or mobile?
Click here to know the process of updating your contact details in KYC records.

Verify your contact details

Step 2 of 3

You already have 4 folios with us. Verify details of any one to proceed.

	Folio no.	Email ID	Mobile no.
	70****76	abh************[email protected]	******6665
	42***02	abh************[email protected]	******6665

Not able to access above email or mobile?

Verify your contact as per KYC records

Not able to access above email or mobile?
Verify your contact as per KYC records

DSP Healthcare Fund

DSP Healthcare Fund

This is an Equity Sectoral/Thematic, Pharma fund with BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk.

Things to know before you invest

What is in DSP Healthcare Fund?

Why should one invest in DSP Healthcare Fund?

Who should invest in DSP Healthcare Fund?

Rethink before you invest

Fund managers:

Portfolio

Current Allocation

Indicators

Compare Performance

Invested Amount

Invested Amount

Fund Details

Fund Details

Investment Objective

Fund Type

Riskometer

Minimum Investment

Fund Documents

Products Offered

Product Information

For Investors

Other Information

Mobile Number

Email Address

Enter the OTP sent to

updated successfully.

Enter the OTP sent to

updated successfully.

You can opt for your email ID or mobile no. as username too.

DSP Healthcare Fund

DSP Healthcare Fund

This is an Equity Sectoral/Thematic, Pharma fund with BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk.

Things to know before you invest

What is in DSP Healthcare Fund?

Why should one invest in DSP Healthcare Fund?

Who should invest in DSP Healthcare Fund?

Rethink before you invest

Fund managers:

Portfolio

Current Allocation

Indicators

Compare Performance

Invested Amount

Invested Amount

Fund Details

Fund Details

Investment Objective

Fund Type

Riskometer

Minimum Investment

Fund Documents

To proceed, we need to first verify your KYC status.

As an additional authentication, we need to verify your contact details.